Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5227545 | 1.00 | SMN1; SMN2 (0.43) | SMN1; SMN2KDM4EPOLBMAPTALDH1A1 | |
| SCHEMBL5223653 | 0.88 | HTR1A (0.40) | SMN1; SMN2KDM4EMAPTALDH1A1LMNA | |
| SCHEMBL4038112 | 0.81 | CYP3A4 (0.51) | POLBACACBCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL4034551 | 0.81 | CYP3A4 (0.51) | POLBACACBCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5225037 | 0.80 | CYP3A4 (0.54) | CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL5228451 | 0.78 | PRMT5 (0.41) | KDM4EPOLBALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL5224914 | 0.78 | PRMT5 (0.41) | KDM4EPOLBALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL5901370 | 0.77 | PKM (0.49) | SMN1; SMN2KDM4EPOLBALDH1A1TLR9 | |
| SCHEMBL5965265 | 0.77 | PKM (0.49) | SMN1; SMN2KDM4EPOLBALDH1A1TLR9 | |
| SCHEMBL4040185 | 0.77 | PKM (0.49) | SMN1; SMN2KDM4EPOLBALDH1A1TLR9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567525-A2 | SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS | CV THERAPEUTICS, INC. (US) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004052887-A2 | SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS | CV THERAPEUTICS, INC. (US) | 2004-06-24 | — | — | WO | disclosed |